The pursuit of endogenous sleep-inducing substances has
been the focus of an extensive, complicated
body of research. Several compounds, including Δ-sleep-inducing
peptide and prostaglandin D2, have been
suggested
to play a role in sleep induction, and yet, the molecular mechanisms of
this physiological process remain largely
unknown. In recent efforts, the cerebrospinal fluid of
sleep-deprived cats was analyzed in search of compounds
that
accumulated during sleep deprivation. An agent with the chemical
formula C18H35NO was found to cycle
with
sleep−wake patterns, increasing in concentration with sleep
deprivation and decreasing in amount upon recovery
sleep. Since the material was generated in minute quantities and
only under the special conditions of sleep deprivation,
efforts to isolate sufficient material for adequate characterization,
structure identification, and subsequent detailed
evaluation of its properties proved unrealistic. With the trace
amounts of the impure endogenous compound available,
extensive MS studies on the agent were completed, revealing key
structural features of the molecule including two
degrees of unsaturation, a long alkyl chain, and a nitrogen substituent
capable of fragmenting as ammonia.
Additionally, HPLC traces suggested a weak UV absorbance for the
unknown material. With this data in hand and
encouraged by the relatively small size of the molecule, MW = 281, a
synthetic approach toward the structural
identification of the natural compound was initiated. Herein, we
report the full details of the synthesis and comparative
characterization of candidate structures for this endogenous agent that
led to the unambiguous structural correlation
with synthetic cis-9-octadecenamide.